QGEN
Qiagen NV
Price:  
41.12 
USD
Volume:  
3,625,535.00
Netherlands | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

QGEN EV/EBITDA

27.5%
Upside

As of 2026-03-13, the EV/EBITDA ratio of Qiagen NV (QGEN) is 12.71. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. QGEN's latest enterprise value is 9,286.14 mil USD. QGEN's TTM EBITDA according to its financial statements is 730.42 mil USD. Dividing these 2 quantities gives us the above QGEN EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 12.5x - 15.5x 14.0x
Forward P/E multiples 15.3x - 21.7x 18.6x
Fair Price 40.22 - 69.98 52.41
Upside -2.2% - 70.2% 27.5%
41.12 USD
Stock Price
52.41 USD
Fair Price

QGEN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-03-12 12.71
2026-03-11 12.74
2026-03-10 13.24
2026-03-09 13.34
2026-03-06 13.68
2026-03-05 14.21
2026-03-04 14.34
2026-03-03 14.56
2026-03-02 14.89
2026-02-27 15.16
2026-02-26 14.96
2026-02-25 14.83
2026-02-24 14.79
2026-02-23 14.50
2026-02-20 14.81
2026-02-19 14.74
2026-02-18 14.94
2026-02-17 14.87
2026-02-13 15.33
2026-02-12 15.46
2026-02-11 15.52
2026-02-10 15.52
2026-02-09 15.44
2026-02-06 15.49
2026-02-05 15.56
2026-02-04 15.70
2026-02-03 15.75
2026-02-02 15.83
2026-01-30 16.25
2026-01-29 16.26
2026-01-28 16.34
2026-01-27 16.41
2026-01-26 16.41
2026-01-23 16.80
2026-01-22 16.42
2026-01-21 16.81
2026-01-20 16.75
2026-01-16 14.53
2026-01-15 14.76
2026-01-14 14.50
2026-01-13 14.43
2026-01-12 14.44
2026-01-09 14.74
2026-01-08 14.78
2026-01-07 14.46
2026-01-06 14.37
2026-01-05 14.23
2026-01-02 13.86
2025-12-31 13.80
2025-12-30 13.90